1610 related articles for article (PubMed ID: 15627368)
1. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
2. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.
Cebrián-Losantos B; Reisner E; Kowol CR; Roller A; Shova S; Arion VB; Keppler BK
Inorg Chem; 2008 Jul; 47(14):6513-23. PubMed ID: 18553904
[TBL] [Abstract][Full Text] [Related]
4. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
[TBL] [Abstract][Full Text] [Related]
5. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
[TBL] [Abstract][Full Text] [Related]
6. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
7. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
[TBL] [Abstract][Full Text] [Related]
8. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
9. The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes.
Meyer TJ; Huynh MH
Inorg Chem; 2003 Dec; 42(25):8140-60. PubMed ID: 14658865
[TBL] [Abstract][Full Text] [Related]
10. Hydrocarbon oxidation by beta-halogenated dioxoruthenium(VI) porphyrin complexes: effect of reduction potential (RuVI/V) and C-H bond-dissociation energy on rate constants.
Che CM; Zhang JL; Zhang R; Huang JS; Lai TS; Tsui WM; Zhou XG; Zhou ZY; Zhu N; Chang CK
Chemistry; 2005 Nov; 11(23):7040-53. PubMed ID: 16163758
[TBL] [Abstract][Full Text] [Related]
11. Consequences of N,C,N'- and C,N,N'-coordination modes on electronic and photophysical properties of cyclometalated aryl ruthenium(II) complexes.
Wadman SH; Lutz M; Tooke DM; Spek AL; Hartl F; Havenith RW; van Klink GP; van Koten G
Inorg Chem; 2009 Mar; 48(5):1887-900. PubMed ID: 19235952
[TBL] [Abstract][Full Text] [Related]
12. Trivalent iron and ruthenium complexes with a redox noninnocent (2-mercaptophenylimino)-methyl-4,6-di-tert-butylphenolate(2-) ligand.
Roy N; Sproules S; Weyhermüller T; Wieghardt K
Inorg Chem; 2009 Apr; 48(8):3783-91. PubMed ID: 19361249
[TBL] [Abstract][Full Text] [Related]
13. Valence-state analysis through spectroelectrochemistry in a series of quinonoid-bridged diruthenium complexes [(acac)(2)Ru(mu-L)Ru(acac)(2)](n) (n=+2, +1, 0, -1, -2).
Ghumaan S; Sarkar B; Maji S; Puranik VG; Fiedler J; Urbanos FA; Jimenez-Aparicio R; Kaim W; Lahiri GK
Chemistry; 2008; 14(34):10816-28. PubMed ID: 18924186
[TBL] [Abstract][Full Text] [Related]
14. Structural diversity in supramolecular complexes of MCl(3) (M = As, Sb, Bi) with constrained thio- and seleno-ether ligands.
Levason W; Maheshwari S; Ratnani R; Reid G; Webster M; Zhang W
Inorg Chem; 2010 Oct; 49(19):9036-48. PubMed ID: 20812749
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium complexes of thiaporphyrin and dithiaporphyrin.
Chuang CH; Ou CK; Liu ST; Kumar A; Ching WM; Chiang PC; dela Rosa MA; Hung CH
Inorg Chem; 2011 Dec; 50(23):11947-57. PubMed ID: 22059653
[TBL] [Abstract][Full Text] [Related]
16. Tetranuclear polybipyridyl complexes of Ru(II) and Mn(II), their electro- and photo-induced transformation into di-mu-oxo Mn(III)Mn(IV) hexanuclear complexes.
Romain S; Baffert C; Dumas S; Chauvin J; Leprêtre JC; Daveloose D; Deronzier A; Collomb MN
Dalton Trans; 2006 Dec; (48):5691-702. PubMed ID: 17146534
[TBL] [Abstract][Full Text] [Related]
17. Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.
Ravera M; Baracco S; Cassino C; Zanello P; Osella D
Dalton Trans; 2004 Aug; (15):2347-51. PubMed ID: 15278129
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and mechanisms of the oxidation of iodide and bromide in aqueous solutions by a trans-dioxoruthenium(VI) complex.
Lam WW; Man WL; Wang YN; Lau TC
Inorg Chem; 2008 Aug; 47(15):6771-8. PubMed ID: 18597422
[TBL] [Abstract][Full Text] [Related]
20. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors.
Maiti BK; Görls H; Klobes O; Imhof W
Dalton Trans; 2010 Jun; 39(24):5713-20. PubMed ID: 20495720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
